HPV and HIV Coinfection: A Complex Interaction Resulting in Epidemiological, Clinical and Therapeutic Implications

• Corey L , WaldA, CelumCL, QuinnTC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr.35(5) , 435–445 (2004).
   PubMed Web of Science ®Google Scholar
• Freeman EE , WeissHA, GlynnJR, CrossPL, WhitworthJA, HayesRJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS20(1) , 73–83 (2006).
   PubMed Web of Science ®Google Scholar
• Romanowski B , MyziukLN, WalmsleySLet al. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada. Sex. Transm. Dis. 36(3) , 165–169 (2009).
   PubMed Web of Science ®Google Scholar
• Veldhuijzen NJ , SnijdersPJ, ReissP, MeijerCJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect. Dis.10(12) , 862–874 (2010).
   PubMed Web of Science ®Google Scholar
• Muñoz N , BoschFX, de Sanjosé S et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med.348(6) , 518–527 (2003).
   PubMed Web of Science ®Google Scholar
• Ferlay J , ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer127(12) , 2893–2917 (2010).
   PubMed Web of Science ®Google Scholar
• Tugizov S , HerreraR, VeluppillaiP, GreenspanD, PalefskyJ. HIV-facilitated paracellular penetration of HPV into mucosal epithelium. Presented at: XIX International AIDS Conference. Washington, DC, USA, 22–27 July 2012.
   Google Scholar
• Vernon SD , HartCE, ReevesWC, IcenogleJP. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res.27(2) , 133–145 (1993).
   PubMed Web of Science ®Google Scholar
• Tornesello ML , BuonaguroFM, Beth-GiraldoE, GiraldoG. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology36(2) , 57–64 (1993).
   PubMed Web of Science ®Google Scholar
• Dolei A , CurreliS, MarongiuPet al. Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. J. Gen. Virol. 80 , 2937–2944 (1999).
   PubMed Web of Science ®Google Scholar
• Bélec L , GherardiR, PayanCet al. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 7(6) , 568–574 (1995).
   PubMed Web of Science ®Google Scholar
• Gonçalves MA , SoaresEG, DonadiEA. The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity. Infect. Agent Cancer4 , 11 (2009).
   PubMedGoogle Scholar
• Ahdieh L , KleinR, BurkRet al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J. Infect. Dis. 184 , 682–690 (2001).
   PubMed Web of Science ®Google Scholar
• Palefsky JM . Cervical human papillomavirus infection and cervical intraepithelial neoplasia and cancer in the era of highly active antiretroviral therapy. Curr. Opin. Oncol.15 , 382–388 (2003).
   PubMed Web of Science ®Google Scholar
• Strickler HD , BurkRD, FazzariMet al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J. Natl Cancer Inst. 97(8) , 577–586 (2005).
   PubMedGoogle Scholar
• Konopnicki D , ManigartY, GillesCet al. High-risk human papillomavirus infection in HIV-positive African women living in Europe. J. Int. AIDS Soc. 16 , 18023 (2013).
   PubMed Web of Science ®Google Scholar
• Muñoz N , MendezF, PossoHet al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J. Infect. Dis. 190(12) , 2077–2087 (2004).
   PubMed Web of Science ®Google Scholar
• Franco E , VillaL, SobrinhoPet al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J. Infect. Dis. 180 , 1415–1423 (1999).
   PubMed Web of Science ®Google Scholar
• Mbulawa Z , MaraisD, JohnsonL, CoetzeeD, WilliamsonA. Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J. Infect. Dis.206(1) , 15–27 (2012).
   PubMed Web of Science ®Google Scholar
• Luque A , DemeterL, ReichmanR. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection. J. Infect. Dis.179(6) , 1405–1409 (1999).
   PubMed Web of Science ®Google Scholar
• Swindells S , EvansS, ZackinRet al.; AIDS Clinical Trial Group 722 Study Team. Predictive value of HIV-1 viral load on risk for opportunistic infection. J. Acquir. Immune Defic. Syndr.30(2) , 154–158 (2002).
   PubMed Web of Science ®Google Scholar
• Mocroft A , ReissP, KirkOet al.; Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clin. Infect. Dis.51(5) , 611–619 (2010).
   PubMed Web of Science ®Google Scholar
• Crowley-Nowick P , EllenbergJ, VermundS, DouglasS, HollandC, MoscickiA. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J. Infect. Dis.181(3) , 939–945 (2000).
   PubMed Web of Science ®Google Scholar
• Moscicki A , EllenbergJ, FarhatS, XuJ. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J. Infect. Dis.190(1) , 37–45 (2004).
   PubMed Web of Science ®Google Scholar
• Nowak R , GravittP, MorrisonCet al. Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. J. Infect. Dis. 203(8) , 1182–1191 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang Z , WietgrefeS, LiQet al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl Acad. Sci. USA 101(15) , 5640–5645 (2004).
   PubMed Web of Science ®Google Scholar
• Cheng SH , ChuFY, LinYS, HsuehYM. Influence of age and CD4+ T cell counts on the prevalence of genital human papillomavirus infection among HIV-seropositive men who have sex with men in Taiwan. J. Med. Virol.84(12) , 1876–1883 (2012).
   PubMed Web of Science ®Google Scholar
• Read TR , HockingJS, VodstrcilLAet al. Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS ONE 7(11) , e49324 (2012).
   PubMed Web of Science ®Google Scholar
• Amornthatree K , SriplungH, MitarnunW, NittayanantaW. Impacts of HIV infection and long-term use of antiretroviral therapy on the prevalence of oral human papillomavirus type 16. J. Oral Pathol. Med.41(4) , 309–314 (2012).
   PubMed Web of Science ®Google Scholar
• Massad LS , RiesterKA, AnastosKMet al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women‘s Interagency HIV Study Group. J. Acquir. Immune Defic. Syndr. 21(1) , 33–41 (1999).
   PubMed Web of Science ®Google Scholar
• Ellerbrock TV , ChiassonMA, BushTJet al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283(8) , 1031–1037 (2000).
   PubMed Web of Science ®Google Scholar
• Coleman N , BirleyH, RentonAet al. Immunological events in regressing genital warts. Am. J. Clin. Pathol. 102(6) , 768–774 (1994).
   PubMed Web of Science ®Google Scholar
• Gilles C , ManigartY, KonopnickiD, BarlowP, RozenbergS. Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status. Gynecol. Oncol.96(1) , 112–118 (2005).
   PubMed Web of Science ®Google Scholar
• Machalek DA , PoyntenM, JinFet al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 13(5) , 487–500 (2012).
   PubMed Web of Science ®Google Scholar
• Palefsky JM , HollyEA, HogeboomCJet al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17(4) , 314–319 (1998).
   PubMedGoogle Scholar
• Chaturvedi A , MadeleineM, BiggarR, EngelsE. Risk of human papillomavirus-associated cancers among persons with AIDS. J. Natl Cancer Inst.101(16) , 1120–1130 (2009).
   PubMedGoogle Scholar
• Houlihan CF , LarkeNL, Watson-JonesDet al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 26(17) , 2211–2222 (2012).
   PubMed Web of Science ®Google Scholar
• Chin -Hong PV , HusnikM, CranstonRDet al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 23(9) , 1135–1142 (2009).
   PubMed Web of Science ®Google Scholar
• Laga M , ManokaA, KivuvuMet al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7(1) , 95–102 (1993).
   PubMed Web of Science ®Google Scholar
• Laurson J , KhanS, ChungR, CrossK, RajK. Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein. Carcinogenesis31(5) , 918–926 (2010).
   PubMed Web of Science ®Google Scholar
• Averbach SH , GravittPE, NowakRGet al. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. AIDS 24(7) , 1035–1042 (2010).
   PubMed Web of Science ®Google Scholar
• Tobian AA , GrabowskiMK, KigoziGet al. Human papillomavirus clearance among males is associated with HIV acquisition and increased dendritic cell density in the foreskin. J. Infect. Dis. 207(11) , 1713–1722 (2013).
   PubMed Web of Science ®Google Scholar
• Mbulawa ZZ , CoetzeeD, MaraisDJet al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J. Infect. Dis. 199(10) , 1514–1524 (2009).
   PubMed Web of Science ®Google Scholar
• Bruni L , DiazM, CastellsaguéX, FerrerE, BoschFX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis.202(12) , 1789–1799 (2010).
   PubMed Web of Science ®Google Scholar
• Clifford GM , GonçalvesMA, Franceschi S; HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS20(18) , 2337–2344 (2006).
   PubMed Web of Science ®Google Scholar
• Ndiaye C , AlemanyL, NdiayeNet al. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences? Trop. Med. Int. Health. 17(12) , 1432–1440 (2012).
   PubMed Web of Science ®Google Scholar
• Bratcher LF , SahasrabuddheVV. The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect. Agent Cancer5 , 8 (2010).
   PubMedGoogle Scholar
• Shrestha S , SudengaS, SmithJ, BachmannL, WilsonC, KempfM. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect. Dis.10 , 295 (2010).
   PubMedGoogle Scholar
• Fife K , WuJ, SquiresK, WattsD, AndersenJ, BrownDR. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr.51(3) , 274–282 (2009).
   PubMed Web of Science ®Google Scholar
• Minkoff H , ZhongY, BurkRet al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J. Infect. Dis. 201(5) , 681–690 (2010).
   PubMed Web of Science ®Google Scholar
• Konopnicki D , ManigartY, GillesCet al. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. J. Infect. Dis. 207(11) , 1723–1729 (2013).
   PubMed Web of Science ®Google Scholar
• Blitz S , BaxterJ, RaboudJet al.; Canadian Women‘s HIV Study Group. Evaluation of HIV and HAART on the natural history of HPV infection and cervical cytopathology in HIV-positive and high risk HIV-negative women. J. Infect. Dis.208(3) , 454–462 (2013).
   PubMed Web of Science ®Google Scholar
• Soncini E , ZoncadaA, CondemiV, AntoniAD, BocchialiniE, SoregottiP. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy. Acta Biomed.78(1) , 36–40 (2007).
   PubMedGoogle Scholar
• Adler DH , KakinamiL, ModisenyaneTet al. Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART. AIDS 26(13) , 1645–1652 (2012).
   PubMed Web of Science ®Google Scholar
• Piketty C , DarraghTM, Da Costa M et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann. Intern. Med.138(6) , 453–459 (2003).
   PubMed Web of Science ®Google Scholar
• Palefsky JM , HollyEA, RalstonMLet al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J. Acquir. Immune Defic. Syndr. 28(5) , 422–428 (2001).
   PubMed Web of Science ®Google Scholar
• Piketty C , DarraghTM, HeardIet al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex. Transm. Dis. 31(2) , 96–99 (2004).
   PubMed Web of Science ®Google Scholar
• Palefsky JM , HollyEA, EfirdcJTet al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19(13) , 1407–1414 (2005).
   PubMed Web of Science ®Google Scholar
• Piketty C , Cochand-PriolletB, LanoyEet al.; Valparaiso Study Group. Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART. AIDS27(3) , 401–406 (2013).
   PubMed Web of Science ®Google Scholar
• de Pokomandy A , RouleauD, GhattasGet al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin. Infect. Dis. 52(9) , 1174–1181 (2011).
   PubMed Web of Science ®Google Scholar
• vander Snoek EM , van der Ende ME, den Hollander JC, Schutten M, Neumann HA, van Doornum GJ. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men. Sex. Transm. Dis.39(7) , 495–500 (2012).
   PubMed Web of Science ®Google Scholar
• Dal Maso L , PoleselJ, SerrainoDet al.; Cancer and AIDS Registries Linkage (CARL) Study. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br. J. Cancer100(5) , 840–847 (2009).
   PubMed Web of Science ®Google Scholar
• Palefsky JM . Antiretroviral therapy and anal cancer: the good, the bad, and the unknown. Sex. Transm. Dis.39(7) , 501–503 (2012).
   PubMed Web of Science ®Google Scholar
• Silverberg MJ , LauB, JusticeACet al.; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin. Infect. Dis.54(7) , 1026–1034 (2012).
   PubMed Web of Science ®Google Scholar
• Bruyand M , RyomL, ShepherdLet al.; D:A:D Study Group. Cancer risk and use of PI or NNRTI-based combination antiretroviral therapy(cART): the D:A:D study. Presented at: 20th Conference on Retroviruses and Opportunistic infections. Atlanta, GA, USA, 3–6 March 2013.
   Google Scholar
• Mbang P , KowalkowskiM, ChiaoE. The impact of protease inhibitors on the incidence of HIV-associated squamous cell carcinoma of the anus. Presented at: 20th Conference on Retroviruses and Opportunistic infections. Atlanta, GA, USA, 3–6 March 2013.
   Google Scholar
• Wiesmann F , ElderingG, BraunP, PanstrugaP, EhretR, KnetctenH. Impact of protease inhibitor containing therapy on human papilloma virus coinfections in HIV-1 positive patients. Presented at: XIX International AIDS Conference. Washington, DC, USA, 22–27 July 2012.
   Google Scholar
• FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med.356(19) , 1915–1927 (2007).
   PubMed Web of Science ®Google Scholar
• Paavonen J , NaudP, SalmerónJet al.; HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet374(9686) , 301–314 (2009).
   PubMed Web of Science ®Google Scholar
• Kreimer AR , GonzálezP, KatkiHAet al.; CVT Vaccine Group. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol.12(9) , 862–870 (2011).
   PubMed Web of Science ®Google Scholar
• Giuliano AR , PalefskyJM, GoldstoneSet al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N. Engl. J. Med. 364(5) , 401–411 (2011).
   PubMed Web of Science ®Google Scholar
• Palefsky JM , GiulianoAR, GoldstoneSet al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N. Engl. J. Med. 365(17) , 1576–1585 (2011).
   PubMed Web of Science ®Google Scholar
• Levin M , MoscickiA, SongLet al. Safety and immunogenicity of a quadrivalent human papillomavirus (type 6, 11, 16 and 18) vaccine in HIV-infected children 7 to 12 years old. J. Acquir. Immune Defic. Syndr. 55(2) , 197–204 (2010).
   PubMed Web of Science ®Google Scholar
• Kahn J , XuJ, KapogiannisBet al. Immunogenicity of the HPV-6, -11, -16, -18 vaccine in HIV-positive young women. Presented at: XIX International AIDS Conference. Washington, DC, USA, 22–27 July 2012.
   Google Scholar
• Kojic E , CespedesM, UmblejaTet al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-positive women. Presented at: XIX International AIDS Conference. Washington, DC, USA, 22–27 July 2012.
   Google Scholar
• Wilkin T , LeeJY, LensingSYet al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J. Infect. Dis. 202(8) , 1246–1253 (2010).
   PubMed Web of Science ®Google Scholar
• Sahasrabuddhe VV , CastlePE, FollansbeeSet al. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J. Infect. Dis. 207(3) , 392–401 (2013).
   PubMed Web of Science ®Google Scholar
• Serrano B , AlemanyL, TousSet al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect. Agent Cancer 7(1) , 38 (2012).
   PubMed Web of Science ®Google Scholar
• Tabrizi SN , BrothertonJM, KaldorJMet al. Fall in human papillomavirus prevalence following a national vaccination program. J. Infect. Dis. 206(11) , 1645–1651 (2012).
   PubMed Web of Science ®Google Scholar
• Ali H , GuyRJ, WandHet al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect. Dis. 13 , 140 (2013).
   PubMed Web of Science ®Google Scholar
• Kenter GG , WeltersMJ, ValentijnARet al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N. Engl. J. Med. 361(19) , 1838–1847 (2009).
   PubMed Web of Science ®Google Scholar
• Anderson JS , HoyJ, HillmanRet al. A randomized, placebo-controlled, dose-escalation study to determine the safety, tolerability, and immunogenicity of an HPV-16 therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus. J. Acquir. Immune Defic. Syndr. 52(3) , 371–381 (2009).
   PubMed Web of Science ®Google Scholar

Websites

• US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://aidsinfo.nih.gov/Guidelines (Accessed 6April2012)
   Google Scholar
• WHO. 2010: a global view of HIV infection. www.unaids.org/documents/20101123_2010_HIV_Prevalence_Map_em.pdf (Accessed 23November2010)
   Google Scholar